Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Only a revision version update is shown (Revision: v3.3.4 added; Revision: v3.3.3 removed). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:21:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The Locations section has been expanded to display a broad list of study sites across multiple countries and regions, with specific centers listed.
    Difference
    2%
    Check dated 2025-12-23T09:14:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:44:38.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill notice and updated the Revision to v3.3.1; the previous PubMed note Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:45:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Removed the administrative notice about a lapse in government funding and potential outdated information. The page now displays the study details without the funding-status banner.
    Difference
    0.1%
    Check dated 2025-11-17T07:13:08.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    No significant additions or deletions were identified; the page’s core details (title, trial design, interventions, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:20:52.000Z thumbnail image

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.